Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Contributions to Nephrology
|
January 1, 1986
Ciclosporin does not inhibit the early steps of lymphocyte activation
B Brando, G Civati, G Busnach, et al.
Transplantation
|
May 1, 1988
The Milan clinical trial with cyclosporine in cadaveric renal transplantation. A three-year follow-up
C Ponticelli, L Minetti, F Q Di Palo, et al.
Clinical Nephrology
|
August 31, 2006
Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients
M Salvadori, H Holzer, G Civati, et al.
Nephron
|
January 1, 1990
Erythrocyte ferritin in patients on chronic hemodialysis treatment
C Brunati, A Piperno, C Guastoni, et al.
Minerva Nefrologica
|
April 1, 1981
[The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration]
G Civati, C Guastoni, A Perego, et al.
Transplantation Proceedings
|
February 1, 1987
The Leu-2+7+ cell subset as a marker of immune activation in renal transplant recipients
B Brando, G Civati, G Busnach, et al.
Transplantation Proceedings
|
September 27, 2005
Laparosopic hand-assisted living donor nephrectomy: the Niguarda experience
G Maione, C V Sansalone, P Aseni, et al.
American Journal of Nephrology
|
January 1, 1992
Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin
C Brunati, M D Cappellini, T De Feo, et al.
The Journal of Infection
|
July 1, 1983
Immune response to hepatitis B vaccine in staff and patients in renal dialysis units
F Bergamini, A R Zanetti, P Ferroni, et al.
Transplantation Proceedings
|
September 27, 2005
Surgical complications are the main cause of pancreatic allograft loss in pancreas-kidney transplant recipients
C V Sansalone, G Maione, P Aseni, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Contributions to Nephrology
|
January 1, 1986
Ciclosporin does not inhibit the early steps of lymphocyte activation
B Brando, G Civati, G Busnach, et al.
Transplantation
|
May 1, 1988
The Milan clinical trial with cyclosporine in cadaveric renal transplantation. A three-year follow-up
C Ponticelli, L Minetti, F Q Di Palo, et al.
Clinical Nephrology
|
August 31, 2006
Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients
M Salvadori, H Holzer, G Civati, et al.
Nephron
|
January 1, 1990
Erythrocyte ferritin in patients on chronic hemodialysis treatment
C Brunati, A Piperno, C Guastoni, et al.
Minerva Nefrologica
|
April 1, 1981
[The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration]
G Civati, C Guastoni, A Perego, et al.
Transplantation Proceedings
|
February 1, 1987
The Leu-2+7+ cell subset as a marker of immune activation in renal transplant recipients
B Brando, G Civati, G Busnach, et al.
Transplantation Proceedings
|
September 27, 2005
Laparosopic hand-assisted living donor nephrectomy: the Niguarda experience
G Maione, C V Sansalone, P Aseni, et al.
American Journal of Nephrology
|
January 1, 1992
Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin
C Brunati, M D Cappellini, T De Feo, et al.
The Journal of Infection
|
July 1, 1983
Immune response to hepatitis B vaccine in staff and patients in renal dialysis units
F Bergamini, A R Zanetti, P Ferroni, et al.
Transplantation Proceedings
|
September 27, 2005
Surgical complications are the main cause of pancreatic allograft loss in pancreas-kidney transplant recipients
C V Sansalone, G Maione, P Aseni, et al.
Page
of 8